Drug development

#bit bio #CAR-T #CRISPR #Drug development #Drug discovery #Stem cells #Synthetic biology #Synthetic DNA

New podcast: An overview on the impact of synthetic biology

This is the latest episode of the free DDW narrated podcast, titled “An overview on the impact of synthetic biology”, which covers two articles written for DDW Volume 24 – Issue 3, Summer 2023. They are called: “Synthetic biology: Impacting drug discovery” and “Synthetic biology: Innovating in drug… Read More

#News

#Cancer research #Cell therapy #Drug development #Drug discovery #Oncology

New DDW Highlights podcast: 24 March 2025

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. This week the DDW news round-up takes a look at developments in cancer research,… Read More

#News

#Cancer research #Cell therapy #Drug development #Drug discovery #Oncology

This week in drug discovery (17-21 March) 

News round-up for 17-21 March by DDW Senior Digital Content Editor Diana Spencer. This week the DDW news round-up takes a look at developments in cancer research, including AZ’s acquisition of EsoBiotec, positive trial results for an allogeneic T-cell therapy, and a new drug target for glioblastoma. Read More

#News

TEM micrograph of kidney proximal tubule cells
#Drug development #Drug discovery #Drug toxicity #eBook #In vitro #In vitro assays

eBook: A guide to predictive in vitro renal proximal tubule models

This latest eBook provides a comprehensive guide to predictive in vitro renal proximal tubule models for safety, efficacy and transporter studies. The Newcells Renal Proximal Tubule Cells Model eBook covers topics including: Cross-species comparison of drug handling Transporter mediated drug-drug interactions Drug-induced renal toxicity New drug modalities e.g. RNA therapeutics… Read More

#News

#Drug development #Drug discovery #Drug toxicity #In vitro #In vitro assays

Your comprehensive guide to predictive in vitro renal proximal tubule models for safety, efficacy and transporter studies

The Newcells Renal Proximal Tubule Cells Model eBook covers topics including: Cross-species comparison of drug handling Transporter mediated drug-drug interactions Drug-induced renal toxicity New drug modalities e.g. RNA therapeutics and how to measure mitochondrial health… Read More

#Resources

#Clinical trial design #Clinical trials #Drug development #Drug discovery

New DDW Highlights podcast: 17 March 2025

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. Clinical trials of all stages have dominated the DDW news section this week. All… Read More

#News

#Clinical trial design #Clinical trials #Drug development #Drug discovery

This week in drug discovery (10-14 March) 

News round-up for 10-14 March by DDW Senior Digital Content Editor Diana Spencer. Clinical trials of all stages have dominated the DDW news section this week. All the stories represent a significant step forward for drug discovery, either due to the innovative nature of the therapies being studied,… Read More

#News

Monoclonal antibodies
#Antibodies #Biotechnology #Collaboration #Drug development #Drug discovery #Pierre Fabre Laboratories #RedRidge

Pharma/biotech biparatopic antibody collaboration agreed

Pierre Fabre Laboratories and RedRidge have announced an exclusive R&D collaboration and license agreement to identify and develop biparatopic antibody (BPA) drug candidates against multiple targets. In line with Pierre Fabre Laboratories’ innovation strategy, the partnership’s therapeutic focus will be on precision oncology as well as dermatology and rare diseases. Read More

#News

#Antibody drug conjugate (ADC) #Big pharma #Drug development #Drug discovery #Heidelberg Pharma #Takeda #Therapeutic Antibodies

A global overview of therapeutic antibody development

DDW’s Megan Thomas takes a wide-angle look at the sector and speaks to experts and thought leaders about their predictions for therapeutic antibodies in 2025. Clinical advancements Marcelo Freire, Vice President of Global Medical Affairs, Therapeutic Area Head of Gastroenterology at Takeda, comments on monoclonal antibodies (mAbs) from a gastro… Read More

#Business & Investment #Exclusive Content

#2025 predictions #Drug development #Drug discovery #Regulatory

New modalities: Industry predictions for 2025

DDW’s Megan Thomas spoke with industry experts about their predictions for drug discovery opportunities in 2025. Previously, with a focus on technology, machine learning (ML) and artificial intelligence (AI), as well as neuroscience, cancer research, cell and gene therapy, diagnostics and regulation and drug policy. This is the final article in this series, covering new… Read More

#Exclusive Content #Regulatory #Trends & Analysis

#Business #Drug development #Drug discovery #Spinout #Start-ups #Turning Science into Business

New DDW Highlights podcast: 10 March 2025

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. Our news round-up this week focuses on start-ups, the innovative fledgling companies that are… Read More

#News

#Business #Drug development #Drug discovery #Spinout #Start-ups #Turning Science into Business

This week in drug discovery (3-7 March) 

News round-up for 3-7 March by DDW Senior Digital Content Editor Diana Spencer. Our news round-up this week focuses on start-ups, the innovative fledgling companies that are coming through and sparking new life into various areas of drug discovery. The top stories: Start-up… Read More

#News

#Artificial intelligence (AI) #Data management #Drug development #Drug discovery #eBook

New eBook: Three ways to solve scientific FOMO

A new eBook is now available to download entitled ‘Three Ways to Solve Scientific FOMO: Advice for Navigating Early Discovery‘, from CCC / RightsDirect. The authors explore key functions that empower researchers to overcome the challenges of siloed data, including: Leveraging ontologies Utilising search alerts Effectively employing AI… Read More

#News

#Artificial intelligence (AI) #Data management #Drug development #Drug discovery

Unifying Data Sources: A Guide for Efficient, Comprehensive Research

In ‘Three Ways to Solve Scientific FOMO: Advice for Navigating Early Discovery’, we explore key functions that empower researchers to overcome the challenges of siloed data, including: Leveraging ontologies Utilising search alerts Effectively employing AI Read our ebook to learn how you can accelerate your breakthroughs in drug discovery. Read More

#Resources

#2025 predictions #Drug development #Drug discovery #Regulatory

Regulation and drug policy: Industry predictions for 2025

DDW’s Megan Thomas spoke with industry experts about their predictions for drug discovery opportunities in 2025. Previously, with a focus on technology, machine learning (ML) and artificial intelligence (AI), as well as neuroscience, cancer research, cell and gene therapy and diagnostics. Here, looking at regulation and drug policy.  Ariel Katz, CEO & Co-Founder, H1… Read More

#Exclusive Content #Regulatory #Trends & Analysis

#Drug development #Drug discovery #Interview #NanoTemper Technologies #Sitting Down With #Vodcast

New vodcast: Sitting Down With… Philipp Baaske, NanoTemper

DDW’s Megan Thomas caught up with Philipp Baaske, Co-Founder & Executive Chairman of NanoTemper Technologies, about biophysical characterisation techniques for complex biologics. Highlights of the Vodcast As drug discovery moves beyond traditional small molecules, biophysical characterisation techniques must evolve to keep pace with the increasing complexity of new drug… Read More

#News